Company press releases

Released	Company	Title	Industry	Topic
27 Aug 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Number of Shares Constituting the Share Capital	20103010 Biotechnology	General meeting / Board Meeting
27 Aug 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics: Ordinary and Extraordinary General Meeting of September 17, 2026 – Arrangements for the Availability and Consultation of Preparatory Documents	20103010 Biotechnology	General meeting / Board Meeting
27 Aug 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics : ASSEMBLÉE GÉNÉRALE ORDINAIRE ET EXTRAORDINAIRE DU 17 SEPTEMBRE 2026 – MODALITÉS DE MISE À DISPOSITION OU DE CONSULTATION DES DOCUMENTS PRÉPARATOIRES	20103010 Biotechnology	General meeting / Board Meeting
27 Aug 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL	20103010 Biotechnology	General meeting / Board Meeting
07 Aug 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics - Projet de transfert de la cotation de ses titres du marché réglementé d'Euronext Paris vers Euronext Growth Paris	20103010 Biotechnology	General meeting / Board Meeting
07 Aug 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics - Proposed Transfer of the Listing of Its Securities From the Regulated Market of Euronext Paris to Euronext Growth Paris	20103010 Biotechnology	General meeting / Board Meeting
29 Jul 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	20103010 Biotechnology	Other subject
29 Jul 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL	20103010 Biotechnology	Other subject
27 Jul 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics annonce la signature d'un avenant au contrat d'Equity Line et de prêt de titres entre son actionnaire principal ABL SA (Luxembourg) et Alumni Capital	20103010 Biotechnology	Other subject
27 Jul 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital	20103010 Biotechnology	Other subject
23 Jul 2026 09:22 CEST	ABL Diagnostics	ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations	20103010 Biotechnology	Other financial transaction
23 Jul 2026 09:22 CEST	ABL Diagnostics	ABL Diagnostics désignée par le Tribunal de commerce d'Évry pour la reprise des activités de TEXCELL	20103010 Biotechnology	Other financial transaction
22 Jul 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL	20103010 Biotechnology	Other financial transaction
22 Jul 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	20103010 Biotechnology	Other financial transaction
15 Jul 2026 08:00 CEST	ABL Diagnostics	ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold	20103010 Biotechnology	Legal
15 Jul 2026 08:00 CEST	ABL Diagnostics	ABL Diagnostics informée du franchissement à la baisse du seuil de 95 % par son actionnaire de référence ABL	20103010 Biotechnology	Legal
13 Jul 2026 08:00 CEST	ABL Diagnostics	ABL DIAGNOSTICS : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ S1 2026	20103010 Biotechnology	Legal
10 Jul 2026 08:00 CEST	ABL Diagnostics	ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL	20103010 Biotechnology	Share history
10 Jul 2026 08:00 CEST	ABL Diagnostics	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	20103010 Biotechnology	Share history
02 Jul 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics - Approbation du versement de dividendes au titre de l’exercice 2025	20103010 Biotechnology	Dividend
02 Jul 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics – Approval of Dividend Distribution for Fiscal Year 2025	20103010 Biotechnology	Dividend
18 Jun 2026 13:51 CEST	ABL Diagnostics	ABL Diagnostics: Growth Trajectory Confirmed and Strong Upside Potential Identified	20103010 Biotechnology	Trends / Analyses
18 Jun 2026 13:51 CEST	ABL Diagnostics	ABL Diagnostics : trajectoire de croissance confirmée et fort levier de revalorisation identifié	20103010 Biotechnology	Trends / Analyses
12 Jun 2026 08:00 CEST	ABL Diagnostics	ABL Diagnostics and CDL Pharma Secure a Multi-year International Contract of up to €2.7 Million Through 2031	20103010 Biotechnology	News contracts
12 Jun 2026 08:00 CEST	ABL Diagnostics	ABL Diagnostics et CDL Pharma remportent un contrat international pluriannuel pouvant atteindre 2,7 M€ jusqu’en 2031	20103010 Biotechnology	News contracts
10 Jun 2026 08:00 CEST	ABL Diagnostics	ABL Diagnostics (ABLD) Announces the Submission of a Takeover Bid for Texcell France	20103010 Biotechnology	Takeover bids
10 Jun 2026 08:00 CEST	ABL Diagnostics	ABL Diagnostics (ABLD) annonce le dépôt d’une offre de reprise de Texcell France	20103010 Biotechnology	Takeover bids
10 Jun 2026 00:00 CEST	ABL Diagnostics	ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Total Number of Shares Composing the Share Capital	20103010 Biotechnology	General meeting / Board Meeting
10 Jun 2026 00:00 CEST	ABL Diagnostics	ABL Diagnostics: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL	20103010 Biotechnology	General meeting / Board Meeting
09 Jun 2026 19:00 CEST	ABL Diagnostics	ABL Diagnostics : Assemblée Générale Ordinaire et Extraordinaire du 30 juin 2026 – Modalités de mise à disposition ou de consultation des documents préparatoires	20103010 Biotechnology	General meeting / Board Meeting
09 Jun 2026 19:00 CEST	ABL Diagnostics	ABL Diagnostics: Ordinary and Extraordinary General Meeting of June 30, 2026 – Terms for Making Available or Consulting Preparatory Documents	20103010 Biotechnology	General meeting / Board Meeting
05 Jun 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics: Sale of a new block of shares by its main shareholder ABL	20103010 Biotechnology	Share history
05 Jun 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL	20103010 Biotechnology	Share history
04 Jun 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	20103010 Biotechnology	Share history
04 Jun 2026 18:00 CEST	ABL Diagnostics	ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL	20103010 Biotechnology	Share history
01 Jun 2026 18:06 CEST	ABL Diagnostics	ABL DIAGNOSTICS PRÉSENTE SA FEUILLE DE ROUTE FINANCIÈRE ET SES PERSPECTIVES DE CROISSANCE POUR 2026	20103010 Biotechnology	Legal
01 Jun 2026 18:06 CEST	ABL Diagnostics	ABL Diagnostics Presents Its Financial Roadmap and Growth Outlook for 2026	20103010 Biotechnology	Legal
19 May 2026 18:00 CEST	ABL Diagnostics	Allinvest Reiterates Its "BUY" Rating on ABL Diagnostics and Maintains a €8.4 Target Price (Representing a 2.2X Multiple)	20103010 Biotechnology	Trends / Analyses
19 May 2026 18:00 CEST	ABL Diagnostics	ALLINVEST RÉITÈRE SON OPINION « ACHAT » SUR ABL DIAGNOSTICS ET MAINTIENT UN OBJECTIF DE COURS DE 8,4 € (MATÉRIALISANT UN MULTIPLE DE X2,2)	20103010 Biotechnology	Trends / Analyses
18 May 2026 08:00 CEST	ABL Diagnostics	ABL Diagnostics Proposes a Significant Increase in Its Dividend for FY2025	20103010 Biotechnology	Dividend
18 May 2026 08:00 CEST	ABL Diagnostics	ABL Diagnostics propose une augmentation significative de son dividende au titre de l’exercice 2025	20103010 Biotechnology	Dividend
11 May 2026 08:00 CEST	ABL Diagnostics	ABL DIAGNOSTICS PUBLIE DES RÉSULTATS ANNUELS 2025 HISTORIQUES : EXPLOSION DU RÉSULTAT NET (+246%), FORTE RENTABILITÉ OPÉRATIONNELLE ET ACCÉLÉRATION MONDIALE	20103010 Biotechnology	Commercial results
11 May 2026 08:00 CEST	ABL Diagnostics	ABL Diagnostics Reports Historic 2025 Annual Results: Net Income Explosion (+246%), Strong Operating Profitability and Global Acceleration	20103010 Biotechnology	Commercial results
08 May 2026 00:01 CEST	ABL Diagnostics	ABL Diagnostics: Availability of the 2025 Annual Financial Report	20103010 Biotechnology	Legal
08 May 2026 00:01 CEST	ABL Diagnostics	ABL DIAGNOSTICS : MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025	20103010 Biotechnology	Legal
17 Mar 2026 18:00 CET	ABL Diagnostics	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	20103010 Biotechnology	Other financial transaction
17 Mar 2026 18:00 CET	ABL Diagnostics	ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL	20103010 Biotechnology	Other financial transaction
19 Feb 2026 08:00 CET	ABL Diagnostics	ABL Diagnostics Update Regarding Non-Binding Letter of Intent	20103010 Biotechnology	Mergers, Acquisitions, Transfers
19 Feb 2026 08:00 CET	ABL Diagnostics	Mise à jour d’ABL Diagnostics concernant la lettre d’intention non contraignante	20103010 Biotechnology	Mergers, Acquisitions, Transfers
13 Feb 2026 18:00 CET	ABL Diagnostics	ABL SA exécute un premier Avis d’Achat portant sur des actions ABL Diagnostics avec Alumni Capital	20103010 Biotechnology	Other financial transaction

Topic

Provider

Date